Alx Oncology Holdings  (ALXO)

$1.51 -$0.04 (-2.53%) 4:38 PM 12/11/24
NASDAQ | $USD | Biotechnology

Stock Data

  • Market Cap

    $85.44M

  • Day's Range

    $1.51 - $1.59

  • Volume

    1,002,879

  • 52 Week Low / High

    $1.19 - $17.82

  • PE Ratio

    -

  • PEG Ratio

    -

  • Dividend Frequency

    -

ALXO's Dividend
-
Amount
-
Dividend Yield
Nov 30
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
3
Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
$17.07
Target Price

Company News

  • ALX Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference — Jan 3rd, 2024

    ALX Oncology SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, announced today that Jason Lettmann, Chief Exe...

Similar Stocks

No similar stocks found.

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free